As of 2:30 PM on the 13th, Celltrion Healthcare is trading at 110,800 KRW, up 6.64% from the previous day. This marks a 17.25% increase compared to July 31. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have net purchased 488,032 shares of Celltrion Healthcare, and institutions have net purchased 84,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 238,994 shares, while foreigners and institutions have net sold 327,936 shares and net purchased 569,668 shares, respectively.
On August 10, Celltrion Healthcare was highlighted in the market for its "rising trend expected from biosimilar benefits."
[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
